| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.097 | 0.05 |